BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
64 results:

  • 1. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
    Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry.
    Müller JA; Delank KS; Laudner K; Wittenberg I; Zeh A; Vordermark D; Medenwald D
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17051-17069. PubMed ID: 37750956
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognostic significance of the heterologous component in uterine carcinosarcomas.
    Can B; Karataşli V; Çakir İ; Sayhan S; Hansu K; Kuru O
    Rev Assoc Med Bras (1992); 2023; 69(9):e20230517. PubMed ID: 37729375
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
    Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
    Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
    Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
    Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
    Faria C; Tzankov A
    Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis.
    Bensaid S; Contejean A; Morand P; Enser M; Eyrolle L; Charlier C; Kernéis S; Anract P; Biau D; Canouï E;
    J Surg Oncol; 2023 Aug; 128(2):344-349. PubMed ID: 37010035
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus-Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma.
    Wah NW; Mok Y; Omar N; Chang KTE; Tay TKY; Hue SS; Lee VKM
    Mod Pathol; 2023 Jun; 36(6):100127. PubMed ID: 36965331
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
    Yang Y; Shu Y; Tang Y; Zhao S; Jia Y; Ji J; Ma H; Lin T; Zheng K; Xu H; Wu Y
    Cancer Med; 2023 Apr; 12(8):9156-9166. PubMed ID: 36916780
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.
    Dong M; Wu J; Wu R; Wang D; Liu R; Luo H; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
    Radiat Oncol; 2023 Feb; 18(1):31. PubMed ID: 36805784
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The diagnostic value of magnetic resonance imaging-based texture analysis in differentiating enchondroma and chondrosarcoma.
    Cilengir AH; Evrimler S; Serel TA; Uluc E; Tosun O
    Skeletal Radiol; 2023 May; 52(5):1039-1049. PubMed ID: 36434265
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
    Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
    Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
    ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.
    Kokkali S; Kotsantis I; Magou E; Sophia T; Kormas T; Diakoumis G; Spathas N; Psyrri A; Ardavanis A
    Invest New Drugs; 2022 Jun; 40(3):668-675. PubMed ID: 35312944
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature.
    Decruyenaere P; Mazure D; Moors I; Van Dorpe J; Van der Linden M; Denys B; Hofmans M; Offner F
    Acta Clin Belg; 2023 Feb; 78(1):58-66. PubMed ID: 35098906
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Patterns of Cancer Care and Association with Survival among Younger Adolescents and Young Adults: A Population-Based Retrospective Cohort Study.
    Collins CL; Peng J; Singh S; Hamilton AS; Freyer DR
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2105-2113. PubMed ID: 34479948
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Assessment of Secondary sarcomas Among Patients With Cancer of the Abdomen or Pelvis Who Received Combinations of Surgery, Radiation, and Chemotherapy vs Surgery Alone.
    Hird AE; Magee DE; Matta R; Saskin R; Dvorani E; Kulkarni GS; Kodama R; Herschorn S; Narod SA; Nam RK
    JAMA Netw Open; 2020 Oct; 3(10):e2013929. PubMed ID: 33006617
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
    Wang B; Chen LJ; Wang XY
    Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21).
    Hu G; Lu A; Wu J; Jia Y; Zuo Y; Ding M; Zhang L
    Pediatr Hematol Oncol; 2021 Feb; 38(1):14-24. PubMed ID: 32803999
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Proposed Staging System for Improved Prognostication of MDM2-amplified Liposarcoma.
    Tucci JJ; Dashti NK; Cates JMM
    Am J Surg Pathol; 2021 Jan; 45(1):101-107. PubMed ID: 32796171
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.